nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Sepsis—Etoposide—testicular cancer	0.00681	0.00681	CcSEcCtD
Conivaptan—Phlebitis—Etoposide—testicular cancer	0.00662	0.00662	CcSEcCtD
Conivaptan—Hypokalaemia—Ifosfamide—testicular cancer	0.00657	0.00657	CcSEcCtD
Conivaptan—Pneumonia—Bleomycin—testicular cancer	0.00655	0.00655	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—testicular cancer	0.00641	0.00641	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—testicular cancer	0.00641	0.00641	CcSEcCtD
Conivaptan—Hyponatraemia—Cisplatin—testicular cancer	0.00625	0.00625	CcSEcCtD
Conivaptan—Haematuria—Bleomycin—testicular cancer	0.0062	0.0062	CcSEcCtD
Conivaptan—Pneumonia—Dactinomycin—testicular cancer	0.0061	0.0061	CcSEcCtD
Conivaptan—Anaemia—Chlorambucil—testicular cancer	0.00607	0.00607	CcSEcCtD
Conivaptan—Cardiac failure—Etoposide—testicular cancer	0.00584	0.00584	CcSEcCtD
Conivaptan—Dehydration—Cisplatin—testicular cancer	0.00579	0.00579	CcSEcCtD
Conivaptan—Pollakiuria—Ifosfamide—testicular cancer	0.00576	0.00576	CcSEcCtD
Conivaptan—Orthostatic hypotension—Cisplatin—testicular cancer	0.00568	0.00568	CcSEcCtD
Conivaptan—Hypokalaemia—Cisplatin—testicular cancer	0.00566	0.00566	CcSEcCtD
Conivaptan—Hyperglycaemia—Ifosfamide—testicular cancer	0.00563	0.00563	CcSEcCtD
Conivaptan—Pneumonia—Ifosfamide—testicular cancer	0.00559	0.00559	CcSEcCtD
Conivaptan—Anaemia—Vinblastine—testicular cancer	0.00557	0.00557	CcSEcCtD
Conivaptan—Infestation NOS—Ifosfamide—testicular cancer	0.00556	0.00556	CcSEcCtD
Conivaptan—Infestation—Ifosfamide—testicular cancer	0.00556	0.00556	CcSEcCtD
Conivaptan—Confusional state—Chlorambucil—testicular cancer	0.00541	0.00541	CcSEcCtD
Conivaptan—Infection—Chlorambucil—testicular cancer	0.00533	0.00533	CcSEcCtD
Conivaptan—Haematuria—Ifosfamide—testicular cancer	0.0053	0.0053	CcSEcCtD
Conivaptan—Hypertension—Vinblastine—testicular cancer	0.0052	0.0052	CcSEcCtD
Conivaptan—Erythema—Bleomycin—testicular cancer	0.00509	0.00509	CcSEcCtD
Conivaptan—Urinary tract disorder—Ifosfamide—testicular cancer	0.00493	0.00493	CcSEcCtD
Conivaptan—Urethral disorder—Ifosfamide—testicular cancer	0.00489	0.00489	CcSEcCtD
Conivaptan—Erythema—Dactinomycin—testicular cancer	0.00474	0.00474	CcSEcCtD
Conivaptan—Anaemia—Bleomycin—testicular cancer	0.0047	0.0047	CcSEcCtD
Conivaptan—Cardiac disorder—Ifosfamide—testicular cancer	0.00463	0.00463	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00463	0.00463	CcSEcCtD
Conivaptan—Pain—Chlorambucil—testicular cancer	0.00459	0.00459	CcSEcCtD
Conivaptan—Angiopathy—Ifosfamide—testicular cancer	0.00453	0.00453	CcSEcCtD
Conivaptan—Mediastinal disorder—Ifosfamide—testicular cancer	0.0045	0.0045	CcSEcCtD
Conivaptan—Feeling abnormal—Chlorambucil—testicular cancer	0.00442	0.00442	CcSEcCtD
Conivaptan—Pneumonia—Etoposide—testicular cancer	0.00442	0.00442	CcSEcCtD
Conivaptan—Infestation NOS—Etoposide—testicular cancer	0.00439	0.00439	CcSEcCtD
Conivaptan—Infestation—Etoposide—testicular cancer	0.00439	0.00439	CcSEcCtD
Conivaptan—Anaemia—Dactinomycin—testicular cancer	0.00438	0.00438	CcSEcCtD
Conivaptan—Mental disorder—Ifosfamide—testicular cancer	0.00437	0.00437	CcSEcCtD
Conivaptan—Erythema—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Conivaptan—Malnutrition—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Conivaptan—Urine output increased—Methotrexate—testicular cancer	0.00425	0.00425	CcSEcCtD
Conivaptan—Urinary tract disorder—Cisplatin—testicular cancer	0.00425	0.00425	CcSEcCtD
Conivaptan—Body temperature increased—Chlorambucil—testicular cancer	0.00424	0.00424	CcSEcCtD
Conivaptan—Urethral disorder—Cisplatin—testicular cancer	0.00422	0.00422	CcSEcCtD
Conivaptan—Pain—Vinblastine—testicular cancer	0.0042	0.0042	CcSEcCtD
Conivaptan—Constipation—Vinblastine—testicular cancer	0.0042	0.0042	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—testicular cancer	0.0042	0.0042	CcSEcCtD
Conivaptan—Confusional state—Bleomycin—testicular cancer	0.00418	0.00418	CcSEcCtD
Conivaptan—Infection—Bleomycin—testicular cancer	0.00412	0.00412	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—testicular cancer	0.00408	0.00408	CcSEcCtD
Conivaptan—Feeling abnormal—Vinblastine—testicular cancer	0.00405	0.00405	CcSEcCtD
Conivaptan—Anaemia—Ifosfamide—testicular cancer	0.00402	0.00402	CcSEcCtD
Conivaptan—Cardiac disorder—Cisplatin—testicular cancer	0.00399	0.00399	CcSEcCtD
Conivaptan—Urinary tract disorder—Etoposide—testicular cancer	0.00389	0.00389	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—testicular cancer	0.00389	0.00389	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Conivaptan—Mediastinal disorder—Cisplatin—testicular cancer	0.00388	0.00388	CcSEcCtD
Conivaptan—Hypotension—Bleomycin—testicular cancer	0.00388	0.00388	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—testicular cancer	0.00387	0.00387	CcSEcCtD
Conivaptan—Infection—Dactinomycin—testicular cancer	0.00385	0.00385	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—testicular cancer	0.00382	0.00382	CcSEcCtD
Conivaptan—Pruritus—Chlorambucil—testicular cancer	0.00379	0.00379	CcSEcCtD
Conivaptan—Hypertension—Ifosfamide—testicular cancer	0.00375	0.00375	CcSEcCtD
Conivaptan—Erythema—Cisplatin—testicular cancer	0.00375	0.00375	CcSEcCtD
Conivaptan—Malnutrition—Cisplatin—testicular cancer	0.00375	0.00375	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—testicular cancer	0.00371	0.00371	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00367	0.00367	CcSEcCtD
Conivaptan—Diarrhoea—Chlorambucil—testicular cancer	0.00367	0.00367	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—testicular cancer	0.00366	0.00366	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—testicular cancer	0.00358	0.00358	CcSEcCtD
Conivaptan—Confusional state—Ifosfamide—testicular cancer	0.00358	0.00358	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—testicular cancer	0.00355	0.00355	CcSEcCtD
Conivaptan—Pain—Bleomycin—testicular cancer	0.00355	0.00355	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—testicular cancer	0.00353	0.00353	CcSEcCtD
Conivaptan—Infection—Ifosfamide—testicular cancer	0.00352	0.00352	CcSEcCtD
Conivaptan—Nervous system disorder—Ifosfamide—testicular cancer	0.00348	0.00348	CcSEcCtD
Conivaptan—Anaemia—Cisplatin—testicular cancer	0.00346	0.00346	CcSEcCtD
Conivaptan—Skin disorder—Ifosfamide—testicular cancer	0.00345	0.00345	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—testicular cancer	0.00343	0.00343	CcSEcCtD
Conivaptan—Feeling abnormal—Bleomycin—testicular cancer	0.00342	0.00342	CcSEcCtD
Conivaptan—Vomiting—Chlorambucil—testicular cancer	0.00341	0.00341	CcSEcCtD
Conivaptan—Diarrhoea—Vinblastine—testicular cancer	0.00336	0.00336	CcSEcCtD
Conivaptan—Hypotension—Ifosfamide—testicular cancer	0.00331	0.00331	CcSEcCtD
Conivaptan—Pain—Dactinomycin—testicular cancer	0.00331	0.00331	CcSEcCtD
Conivaptan—Body temperature increased—Bleomycin—testicular cancer	0.00328	0.00328	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—testicular cancer	0.00327	0.00327	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—testicular cancer	0.00327	0.00327	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—testicular cancer	0.00321	0.00321	CcSEcCtD
Conivaptan—Feeling abnormal—Dactinomycin—testicular cancer	0.00319	0.00319	CcSEcCtD
Conivaptan—Nausea—Chlorambucil—testicular cancer	0.00319	0.00319	CcSEcCtD
Conivaptan—Anaemia—Etoposide—testicular cancer	0.00317	0.00317	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00317	0.00317	CcSEcCtD
Conivaptan—Vomiting—Vinblastine—testicular cancer	0.00312	0.00312	CcSEcCtD
Conivaptan—Headache—Vinblastine—testicular cancer	0.00308	0.00308	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00306	0.00306	CcSEcCtD
Conivaptan—Body temperature increased—Dactinomycin—testicular cancer	0.00306	0.00306	CcSEcCtD
Conivaptan—Infection—Cisplatin—testicular cancer	0.00304	0.00304	CcSEcCtD
Conivaptan—Constipation—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Conivaptan—Pain—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Conivaptan—Nervous system disorder—Cisplatin—testicular cancer	0.003	0.003	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—testicular cancer	0.00297	0.00297	CcSEcCtD
Conivaptan—Skin disorder—Cisplatin—testicular cancer	0.00297	0.00297	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—testicular cancer	0.00297	0.00297	CcSEcCtD
Conivaptan—Hypertension—Etoposide—testicular cancer	0.00296	0.00296	CcSEcCtD
Conivaptan—Pruritus—Bleomycin—testicular cancer	0.00294	0.00294	CcSEcCtD
Conivaptan—Feeling abnormal—Ifosfamide—testicular cancer	0.00292	0.00292	CcSEcCtD
Conivaptan—Nausea—Vinblastine—testicular cancer	0.00292	0.00292	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.0029	0.0029	CcSEcCtD
Conivaptan—Hypotension—Cisplatin—testicular cancer	0.00286	0.00286	CcSEcCtD
Conivaptan—Confusional state—Etoposide—testicular cancer	0.00282	0.00282	CcSEcCtD
Conivaptan—Body temperature increased—Ifosfamide—testicular cancer	0.0028	0.0028	CcSEcCtD
Conivaptan—Infection—Etoposide—testicular cancer	0.00278	0.00278	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—testicular cancer	0.00275	0.00275	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—testicular cancer	0.00272	0.00272	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Conivaptan—Diarrhoea—Dactinomycin—testicular cancer	0.00265	0.00265	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—testicular cancer	0.00265	0.00265	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00264	0.00264	CcSEcCtD
Conivaptan—Vomiting—Bleomycin—testicular cancer	0.00264	0.00264	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—testicular cancer	0.00263	0.00263	CcSEcCtD
Conivaptan—Infestation—Methotrexate—testicular cancer	0.00263	0.00263	CcSEcCtD
Conivaptan—Hypotension—Etoposide—testicular cancer	0.00262	0.00262	CcSEcCtD
Conivaptan—Pain—Cisplatin—testicular cancer	0.00262	0.00262	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Conivaptan—Feeling abnormal—Cisplatin—testicular cancer	0.00252	0.00252	CcSEcCtD
Conivaptan—Pruritus—Ifosfamide—testicular cancer	0.00251	0.00251	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—testicular cancer	0.00251	0.00251	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—testicular cancer	0.00248	0.00248	CcSEcCtD
Conivaptan—Nausea—Bleomycin—testicular cancer	0.00247	0.00247	CcSEcCtD
Conivaptan—Infestation—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Conivaptan—Vomiting—Dactinomycin—testicular cancer	0.00246	0.00246	CcSEcCtD
Conivaptan—Diarrhoea—Ifosfamide—testicular cancer	0.00243	0.00243	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—testicular cancer	0.00242	0.00242	CcSEcCtD
Conivaptan—Body temperature increased—Cisplatin—testicular cancer	0.00242	0.00242	CcSEcCtD
Conivaptan—Pain—Etoposide—testicular cancer	0.0024	0.0024	CcSEcCtD
Conivaptan—Constipation—Etoposide—testicular cancer	0.0024	0.0024	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—testicular cancer	0.00233	0.00233	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—testicular cancer	0.00232	0.00232	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—testicular cancer	0.00231	0.00231	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—testicular cancer	0.0023	0.0023	CcSEcCtD
Conivaptan—Nausea—Dactinomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—testicular cancer	0.00229	0.00229	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Conivaptan—Vomiting—Ifosfamide—testicular cancer	0.00226	0.00226	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—testicular cancer	0.00221	0.00221	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—testicular cancer	0.00219	0.00219	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—testicular cancer	0.00214	0.00214	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—testicular cancer	0.00213	0.00213	CcSEcCtD
Conivaptan—Nausea—Ifosfamide—testicular cancer	0.00211	0.00211	CcSEcCtD
Conivaptan—Diarrhoea—Cisplatin—testicular cancer	0.00209	0.00209	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Conivaptan—Erythema—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Conivaptan—Pruritus—Etoposide—testicular cancer	0.00198	0.00198	CcSEcCtD
Conivaptan—Vomiting—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Conivaptan—Erythema—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—testicular cancer	0.00192	0.00192	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—testicular cancer	0.0019	0.0019	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Conivaptan—Nausea—Cisplatin—testicular cancer	0.00182	0.00182	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Conivaptan—Vomiting—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Conivaptan—Headache—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00174	0.00174	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Conivaptan—Infection—Methotrexate—testicular cancer	0.00167	0.00167	CcSEcCtD
Conivaptan—Nausea—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Conivaptan—Infection—Epirubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00145	0.00145	CcSEcCtD
Conivaptan—Infection—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Conivaptan—Pain—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Conivaptan—Constipation—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Conivaptan—Pain—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Conivaptan—Pain—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Conivaptan—Headache—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—testicular cancer	0.000998	0.000998	CcSEcCtD
Conivaptan—Nausea—Methotrexate—testicular cancer	0.000997	0.000997	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—testicular cancer	0.000994	0.000994	CcSEcCtD
Conivaptan—Headache—Epirubicin—testicular cancer	0.000984	0.000984	CcSEcCtD
Conivaptan—Nausea—Epirubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—testicular cancer	0.000924	0.000924	CcSEcCtD
Conivaptan—Headache—Doxorubicin—testicular cancer	0.00091	0.00091	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—testicular cancer	0.000863	0.000863	CcSEcCtD
